LSC Webinars

  1. Get $mart: 1 Year Out From Phase 1 Injectable Trials, Avoid 3 Expensive Mistakes 3/6/2025

    Learn how to scale up injectable drug production for Phase 1 trials, avoid costly mistakes, and find the right CDMO partner for long-term success.

  2. Bioprocess Optimization: Leveraging Functional DOE With Time-Based Insights 3/5/2025

    Explore the key differences between traditional DOE and Functional DOE as Seongjin Kim demonstrates how the latter enhances bioprocess optimization through a fed-batch cell culture example.

  3. Discovery Through Commercialization: A Biologic Drug's Analytical Journey 3/4/2025

    Gain valuable insights into advanced methods and analysis techniques for high-order structure, physiochemical characterization, cell-based and biochemical assays, and more.

  4. From Research To Reality: Overcoming CMC Challenges In Cell & Gene Therapy 2/20/2025

    Explore the importance of adopting a Quality by Design (QbD) approach in the development process while integrating regulatory and CMC strategies for maximum efficiency and benefit.

  5. De-Risking Early Phase Micronization With Integrated Solid Form Selection 2/18/2025

    Review a case study describing the selection of the optimal solid form of an API designed for pulmonary administration through the pulmonary route.

  6. Contract Manufacturing: Must-Know Trends And Strategies For 2025 2/12/2025

    Regulated industries face rising demand, tech breakthroughs, and regulatory harmonization. Discover how contract manufacturers must leverage AI and cloud solutions to stay agile and compliant in the future.

  7. Essential Considerations For Selecting The Right Biologic Fill/Finish Partner 2/12/2025

    Partnering with a provider that prioritizes quality and yield optimization not only ensures product safety but also helps reduce operational costs.

  8. CMC And Clinical Strategies For Developing Injectable, Oral Peptide Drugs 2/6/2025

    In this session, Chief Scientific Officer Dr. Andy Lewis delves into the key drivers shaping peptide drug development and explores innovative delivery options to enhance therapeutic outcomes.

  9. The Next Frontier In mRNA: Modular Manufacturing For Scalable RNA-LNP Therapies 1/29/2025

    Explore constructing a modular RNA-LNP GMP facility using Cytiva's FlexFactory™ process train in a KUBio™ environment to scale RNA-LNP therapies.

  10. Accelerating Clinical Development: Modern Tools In Process Chemistry 1/23/2025

    Whether you aim to address bottlenecks or explore advanced techniques, gain a practical and forward-thinking perspective to streamline early-phase development with HTE and model-based approaches.